Brawn Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

3.00

3.00

3.00

3.00

3.00

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

3.31

4.22

5.79

6.26

5.66

Loan funds

Secured loans

-

-

-

-

-

Unsecured loans

-

-

-

-

-

Total

6.31

7.22

8.80

9.26

8.66

Uses of funds

Fixed assets

Gross block

0.77

0.67

0.38

0.38

0.36

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

0.40

0.29

0.24

0.20

0.17

Net block

0.37

0.39

0.14

0.18

0.19

Capital work-in-progress

-

-

-

-

-

Investments

-

-

-

-

-

Net current assets

Current assets, loans & advances

14.16

13.40

13.73

20.11

22.33

Less : current liabilities & provisions

8.22

6.56

5.08

11.03

13.86

Total net current assets

5.94

6.83

8.65

9.09

8.47

Miscellaneous expenses not written

-

-

-

-

-

Total

6.31

7.22

8.80

9.26

8.66

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

30.00

30.00

30.00

30.00

30.00